Tumor-infiltrating lymphocyte immunotherapy comes of age: a journey of development in the Surgery Branch, NCI
The early development of tumor-infiltrating lymphocytes into an effective clinical strategy was fundamentally the work of hundreds of scientists and clinicians within the Surgery Branch of the National Cancer Institute under the leadership of Steven Rosenberg. That journey brought new insights into...
Saved in:
| Main Authors: | Steven A Rosenberg, Stephanie L Goff |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/4/e011734.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor-infiltrating lymphocytes for melanoma immunotherapy
by: Oliver Kepp, et al.
Published: (2023-12-01) -
Tumor-infiltrating lymphocytes in NSCLC: from immune surveillance to immunotherapy
by: Haiyi Xue, et al.
Published: (2025-07-01) -
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
by: Shishengnan Song, et al.
Published: (2025-02-01) -
Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling
by: Fatjona Pupuleku Kraja, et al.
Published: (2025-05-01) -
Tumor-infiltrating lymphocytes in Wilms tumor
by: Devendra Kumar Yadav, et al.
Published: (2020-01-01)